enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Dabigatran - Wikipedia

   en.wikipedia.org/wiki/Dabigatran

   Dabigatran, sold under the brand name Pradaxa among others, is an anticoagulant used to treat and prevent blood clots and to prevent stroke in people with atrial fibrillation. [ 6 ] [ 7 ] Specifically it is used to prevent blood clots following hip or knee replacement and in those with a history of prior clots. [ 6 ]

3. Discovery and development of direct thrombin inhibitors

   en.wikipedia.org/wiki/Discovery_and_development...

   In October 2010 the US FDA approved dabigatran etexilate for the prevention of stroke in patients with atrial fibrillation (AF). [ 6 ] [ 10 ] Many pharmaceutical companies have attempted to develop orally bioavailable DTI drugs but dabigatran etexilate is the only one to reach the market.

4. Direct factor Xa inhibitors - Wikipedia

   en.wikipedia.org/wiki/Direct_factor_Xa_inhibitors

   Direct factor Xa inhibitors (xabans) are anticoagulants (blood thinning drugs), used to both treat and prevent blood clots in veins, and prevent stroke and embolism in people with atrial fibrillation (AF). [2] [3]

5. News, Politics, Sports, Mail & Latest Headlines - AOL.com

   www.aol.com/us-news

   Get breaking news and the latest headlines on business, entertainment, politics, world news, tech, sports, videos and much more from AOL

6. Groundbreaking AI brain implant helps stroke survivor ...

   www.aol.com/news/groundbreaking-ai-brain-implant...

   For premium support please call: 800-290-4726 more ways to reach us

7. Obesity drug Wegovy is approved to cut heart attack and ...

   www.aol.com/news/obesity-drug-wegovy-approved...

   The popular weight-loss drug Wegovy, which has helped millions of Americans shed pounds, can now be used to reduce the risk of stroke, heart attacks and other serious cardiovascular problems in ...

8. Cerebroprotectant - Wikipedia

   en.wikipedia.org/wiki/Cerebroprotectant

   A cerebroprotectant (formerly known as a neuroprotectant) is a drug that is intended to protect the brain after the onset of acute ischemic stroke. [1] As stroke is the second largest cause of death worldwide and a leading cause of adult disability, over 150 drugs have been tested in clinical trials to provide cerebroprotection.

9. Tissue-type plasminogen activator - Wikipedia

   en.wikipedia.org/wiki/Tissue-type_plasminogen...

   However, many patients who were eligible for treatment were not treated. [14] [15] tPA has also been given to patients with acute ischemic stroke above age 90 years old. Although a small fraction of patients 90 years and above treated with tPA for acute ischemic stroke recover, most patients have a poor 30-day functional outcome or die. [16]